BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

208 related articles for article (PubMed ID: 20487625)

  • 1. The potential therapeutic role of potassium channel modulators in asthma and chronic obstructive pulmonary disease.
    Malerba M; Radaeli A; Mancuso S; Polosa R
    J Biol Regul Homeost Agents; 2010; 24(2):123-30. PubMed ID: 20487625
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Potential role of potassium channel openers in the treatment of asthma and chronic obstructive pulmonary disease.
    Pelaia G; Gallelli L; Vatrella A; Grembiale RD; Maselli R; De Sarro GB; Marsico SA
    Life Sci; 2002 Jan; 70(9):977-90. PubMed ID: 11862989
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Role of cholinergic-activated KCa1.1 (BK), KCa3.1 (SK4) and KV7.1 (KCNQ1) channels in mouse colonic Cl- secretion.
    Matos JE; Sausbier M; Beranek G; Sausbier U; Ruth P; Leipziger J
    Acta Physiol (Oxf); 2007 Mar; 189(3):251-8. PubMed ID: 17305705
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Potassium channel modulation: a new drug principle for regulation of smooth muscle contractility. Studies on isolated airways and arteries.
    Nielsen-Kudsk JE
    Dan Med Bull; 1996 Dec; 43(5):429-47. PubMed ID: 8960816
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Neuroregulation of mucus secretion by opioid receptors and K(ATP) and BK(Ca) channels in ferret trachea in vitro.
    Ramnarine SI; Liu YC; Rogers DF
    Br J Pharmacol; 1998 Apr; 123(8):1631-8. PubMed ID: 9605570
    [TBL] [Abstract][Full Text] [Related]  

  • 6. The role of potassium ion channels in cough and other reflexes of the airways.
    Sutovska M; Nosalova G; Franova S
    J Physiol Pharmacol; 2007 Nov; 58 Suppl 5(Pt 2):673-83. PubMed ID: 18204182
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Endothelium as target for large-conductance calcium-activated potassium channel openers.
    Wrzosek A
    Acta Biochim Pol; 2009; 56(3):393-404. PubMed ID: 19753330
    [TBL] [Abstract][Full Text] [Related]  

  • 8. BK channel openers inhibit ROS production of isolated rat brain mitochondria.
    Kulawiak B; Kudin AP; Szewczyk A; Kunz WS
    Exp Neurol; 2008 Aug; 212(2):543-7. PubMed ID: 18572168
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Large-conductance, calcium-activated potassium channels: structural and functional implications.
    Ghatta S; Nimmagadda D; Xu X; O'Rourke ST
    Pharmacol Ther; 2006 Apr; 110(1):103-16. PubMed ID: 16356551
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Involvement of potassium channels in the antidepressant-like effect of venlafaxine in mice.
    Bortolatto CF; Jesse CR; Wilhelm EA; Nogueira CW
    Life Sci; 2010 Feb; 86(9-10):372-6. PubMed ID: 20102723
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Current and future therapies for airway mucus hypersecretion.
    Barnes PJ
    Novartis Found Symp; 2002; 248():237-49; discussion 249-53, 277-82. PubMed ID: 12568498
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Natural modulators of large-conductance calcium-activated potassium channels.
    Nardi A; Calderone V; Chericoni S; Morelli I
    Planta Med; 2003 Oct; 69(10):885-92. PubMed ID: 14648389
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Role of different types of potassium channels in the antidepressant-like effect of agmatine in the mouse forced swimming test.
    Budni J; Gadotti VM; Kaster MP; Santos AR; Rodrigues AL
    Eur J Pharmacol; 2007 Dec; 575(1-3):87-93. PubMed ID: 17761162
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Voltage-dependent antagonist/agonist actions of taurine on Ca(2+)-activated potassium channels of rat skeletal muscle fibers.
    Tricarico D; Barbieri M; Conte Camerino D
    J Pharmacol Exp Ther; 2001 Sep; 298(3):1167-71. PubMed ID: 11504816
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Selective blockade of the intermediate-conductance Ca2+-activated K+ channel suppresses proliferation of microvascular and macrovascular endothelial cells and angiogenesis in vivo.
    Grgic I; Eichler I; Heinau P; Si H; Brakemeier S; Hoyer J; Köhler R
    Arterioscler Thromb Vasc Biol; 2005 Apr; 25(4):704-9. PubMed ID: 15662023
    [TBL] [Abstract][Full Text] [Related]  

  • 16. State-dependent block of BK channels by synthesized shaker ball peptides.
    Li W; Aldrich RW
    J Gen Physiol; 2006 Oct; 128(4):423-41. PubMed ID: 16966472
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Activation of large-conductance Ca(2+)-activated K(+) channels depresses basal synaptic transmission in the hippocampal CA1 area in APP (swe/ind) TgCRND8 mice.
    Ye H; Jalini S; Mylvaganam S; Carlen P
    Neurobiol Aging; 2010 Apr; 31(4):591-604. PubMed ID: 18547679
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Treatment of airway mucus hypersecretion.
    Rogers DF; Barnes PJ
    Ann Med; 2006; 38(2):116-25. PubMed ID: 16581697
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Oxyhemoglobin-induced suppression of voltage-dependent K+ channels in cerebral arteries by enhanced tyrosine kinase activity.
    Ishiguro M; Morielli AD; Zvarova K; Tranmer BI; Penar PL; Wellman GC
    Circ Res; 2006 Nov; 99(11):1252-60. PubMed ID: 17068294
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Effects of potassium channel modulators on human detrusor smooth muscle myogenic phasic contractile activity: potential therapeutic targets for overactive bladder.
    Darblade B; Behr-Roussel D; Oger S; Hieble JP; Lebret T; Gorny D; Benoit G; Alexandre L; Giuliano F
    Urology; 2006 Aug; 68(2):442-8. PubMed ID: 16904481
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 11.